Group One Trading’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-300
Closed -$896 8523
2023
Q1
$896 Hold
300
﹤0.01% 6808
2022
Q4
$896 Hold
300
﹤0.01% 6857
2022
Q3
$1K Sell
300
-79,400
-100% -$195K ﹤0.01% 7436
2022
Q2
$236K Buy
79,700
+1,700
+2% +$5.27K ﹤0.01% 4136
2022
Q1
$300K Buy
78,000
+67,400
+636% +$280K ﹤0.01% 4370
2021
Q4
$44K Buy
10,600
+600
+6% +$2.55K ﹤0.01% 6444
2021
Q3
$47K Sell
10,000
-5,700
-36% -$28K ﹤0.01% 6595
2021
Q2
$84K Buy
15,700
+200
+1% +$1.05K ﹤0.01% 6129
2021
Q1
$702K Buy
+15,500
New +$67.2K ﹤0.01% 3642
2020
Q3
Sell
-500
Closed -$2K 6863
2020
Q2
$2K Buy
+500
New +$1.45K ﹤0.01% 5613
2018
Q3
Sell
-18,100
Closed -$172K 5979
2018
Q2
$172K Buy
18,100
+1,000
+6% +$9.58K ﹤0.01% 3172
2018
Q1
$174K Buy
+17,100
New +$175K ﹤0.01% 2888

Other funds holding CO

Group One Trading's CO Position: Q3 2022 in Review

Group One Trading sold out of Global Cord Blood Corporation (CO) in Q3 2022, closing a stake of 2,000 shares — an estimated $4.92K sold.

Group One Trading first reported a position in CO in Q3 2017 and held it in 14 quarters. The position peaked at $399K in Q4 2017. 24 funds tracked by Wall St. Rank hold CO as of Q3 2022.

  • Group One Trading reported no remaining Global Cord Blood Corporation position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 2,000 Global Cord Blood Corporation shares in Q3 2022, an estimated $4.92K.
  • Group One Trading first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 14 quarters.
  • Group One Trading's Global Cord Blood Corporation position peaked at $399K in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.